Roche
2023
The pharmaceutical industry is one of Germany’s most important export industries. In recent years, the export of pharmaceutical products has seen above-average growth compared to the other export sectors. In addition, research and development play a prominent role for pharmaceutical companies.
Our new study for Roche focuses on these two aspects. It examines the extent to which the German pharmaceutical industry is particularly value-added intensive and innovative in its exports.
Compared to those in the other industries, German pharmaceutical exports are characterised by above-average value-added intensity and growth dynamics. This means that the export of pharmaceutical products (for example, worth one million euros) is linked to more domestic value added and jobs than the average German export of one million euros.
In an international comparison, the German pharmaceutical industry is shown to be one of the most important players on the world market and has been able to maintain its share of world exports in recent years.
In terms of research, the German pharmaceutical industry is losing ground on its international competitors:
For this detailed investigation of the German pharmaceutical industry in a national and international comparison, we relied on the available statistical data. This was then analysed with the help of the Prognos model landscape.
To the study (PDF in German)
Further information, in German (Roche website)
Project team: Dr Georg Klose, Dr Andreas Sachs, Johann Weiss
Latest update: 07.12.2023
Senior Project Manager
The Talent Booster Mechanism supports eleven EU regions that are suffering from a decline in the working-age population and a low proportion of university graduates. The first pillar has been successfully implemented.
A shrinking workforce, digitalisation and decarbonisation: Prognos examined the specific effects of global trends on regional labour markets.
The results of the OVERLAP project show that demographic changes, digital transformation and the need for a green transition are simultaneously affecting regions across the EU.
In recent years, Europe has maintained its strong position in the global market for clean energy technologies, but faces growing competition. On behalf of the European Commission, we examined the competitiveness of these technologies.
Germany needs around 166,000 additional full-time places for primary school children by the summer. We are examining how this can be achieved for the Federal Ministry of Education.
The party offers no constructive solutions to any of the current economic challenges. The fact that the Verband der Familienunternehmen is nevertheless opening up to it is dangerous, says Christian Böllhoff in his guest article in Handelsblatt.
How effective are EU cohesion and structural policies in driving green change in Europe? We examined this and other questions together with COWI, Milieu and CSIL on behalf of the European Commission (DG REGIO).
How can smart specialisation be empirically justified and managed? On behalf of the European Commission (DG REGIO), Prognos is implementing the S3 Community of Practice (S3 CoP) together with a network of partners.
For the European Observation Network for Territorial Development and Cohesion (ESPON), we are investigating how regions can work together more effectively to protect the climate.
The Single Market Programme promotes the EU internal market in order to strengthen it, standardise it and make it more competitive. Prognos was involved in the mid-term evaluation of the programme.
We combine economic research and strategy consulting for sustainable decisions in politics, business and society. Our robust data, precise analyses and scientifically based findings enable fact-based progress – financially independent, politically neutral.
